Which Drugmaker Will Be Biggest in 2014? Hint: Not Pfizer

File this under food for thought. I hope this helps stimulate some good investment ideas.

clipped from blogs.wsj.com The drug industry’s about to plunge off a patent cliff, as blockbuster after blockbuster faces generic competition. But some companies are facing a steeper cliff than others. Evaluate Pharma, a data crunching outfit based in London, pooled consensus forecasts to estimate how things will look in 2014. Here’s a list of the top six, based on projected worldwide sales of prescription and over-the-counter drugs in 2014: 2014 RANK COMPANY 2007 RANK 2014 DRUG SALES (EST., $m) 1 Roche 5 49,500 2 Sanofi-Aventis 3 48,011 3 GlaxoSmithKline 2 43,300 4 Novartis 4 42,875 5 Johnson & Johnson 7 32,547 6 Pfizer 1 29,287